MMP9 and breast carcinoma: Chemotherapies such as paclitaxel and 5-Fluorouracil (5-FU), commonly used in breast cancer, have been demonstrated to increase brain-barrier permeability to tumor cells, especially through the BCSFB due to upregulation of MMP-9 leading to Claudin-6 downregulation in the choroid plexus cells [266].